24 related articles for article (PubMed ID: 30287243)
1. Tumor promoting effect of spheroids in an orthotopic prostate cancer mouse model.
Bastian JLD; Zeuschner P; Stöckle M; Junker K; Linxweiler J
Sci Rep; 2024 Apr; 14(1):8835. PubMed ID: 38632341
[TBL] [Abstract][Full Text] [Related]
2. Stromal reactivity differentially drives tumour cell evolution and prostate cancer progression.
Frankenstein Z; Basanta D; Franco OE; Gao Y; Javier RA; Strand DW; Lee M; Hayward SW; Ayala G; Anderson ARA
Nat Ecol Evol; 2020 Jun; 4(6):870-884. PubMed ID: 32393869
[TBL] [Abstract][Full Text] [Related]
3. EGFR as a stable marker of prostate cancer dissemination to bones.
Nastały P; Stoupiec S; Popęda M; Smentoch J; Schlomm T; Morrissey C; Żaczek AJ; Beyer B; Tennstedt P; Graefen M; Eltze E; Maiuri P; Semjonow A; Pantel K; Brandt B; Bednarz-Knoll N
Br J Cancer; 2020 Dec; 123(12):1767-1774. PubMed ID: 32901137
[TBL] [Abstract][Full Text] [Related]
4. Low Tumor-to-Stroma Ratio Reflects Protective Role of Stroma against Prostate Cancer Progression.
Nastały P; Smentoch J; Popęda M; Martini E; Maiuri P; Żaczek AJ; Sowa M; Matuszewski M; Szade J; Kalinowski L; Niemira M; Brandt B; Eltze E; Semjonow A; Bednarz-Knoll N
J Pers Med; 2021 Oct; 11(11):. PubMed ID: 34834440
[TBL] [Abstract][Full Text] [Related]
5. ALDH2 promotes uterine corpus endometrial carcinoma proliferation and construction of clinical survival prognostic model.
Cui YQ; Xiang Y; Meng F; Ji CH; Xiao R; Li JP; Dai ZT; Liao XH
Aging (Albany NY); 2021 Oct; 13(20):23588-23602. PubMed ID: 34670872
[TBL] [Abstract][Full Text] [Related]
6. The Multifaceted Role of Aldehyde Dehydrogenases in Prostate Cancer Stem Cells.
Püschel J; Dubrovska A; Gorodetska I
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572930
[TBL] [Abstract][Full Text] [Related]
7. Low Numbers of Vascular Vessels Correlate to Progression in Hormone-Naïve Prostate Carcinomas Undergoing Radical Prostatectomy.
Smentoch J; Szade J; Żaczek AJ; Eltze E; Semjonow A; Brandt B; Bednarz-Knoll N
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31547460
[TBL] [Abstract][Full Text] [Related]
8. ALDH1 expression correlates with an epithelial-like phenotype and favorable prognosis in lung adenocarcinoma: a study based on immunohistochemistry and mRNA expression data.
Koh YW; Han JH; Haam S; Jung J
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1427-1436. PubMed ID: 30923946
[TBL] [Abstract][Full Text] [Related]
9. The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis.
Zhou C; Sun B
Oral Oncol; 2014 Dec; 50(12):1144-8. PubMed ID: 25264224
[TBL] [Abstract][Full Text] [Related]
10. ALDH1-positive intratumoral stromal cells indicate differentiated epithelial-like phenotype and good prognosis in prostate cancer.
Nastały P; Filipska M; Morrissey C; Eltze E; Semjonow A; Brandt B; Pantel K; Bednarz-Knoll N
Transl Res; 2019 Jan; 203():49-56. PubMed ID: 30287243
[TBL] [Abstract][Full Text] [Related]
11. Somatic aberrations of BRCA1 gene are associated with ALDH1, EGFR, and tumor progression in prostate cancer.
Omari A; Nastały P; Stoupiec S; Bałabas A; Dąbrowska M; Bielińska B; Huss S; Pantel K; Semjonow A; Eltze E; Brandt B; Bednarz-Knoll N
Int J Cancer; 2019 Feb; 144(3):607-614. PubMed ID: 30265376
[TBL] [Abstract][Full Text] [Related]
12. Stromal expression of ALDH1 in human breast carcinomas indicates reduced tumor progression.
Bednarz-Knoll N; Nastały P; Żaczek A; Stoupiec MG; Riethdorf S; Wikman H; Müller V; Skokowski J; Szade J; Sejda A; Wełnicka-Jaśkiewicz M; Pantel K
Oncotarget; 2015 Sep; 6(29):26789-803. PubMed ID: 26305673
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
De Brot M; Rocha RM; Soares FA; Gobbi H
Pathology; 2012 Jun; 44(4):303-12. PubMed ID: 22544210
[TBL] [Abstract][Full Text] [Related]
14. Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.
Miyoshi Y; Shien T; Ogiya A; Ishida N; Yamazaki K; Horii R; Horimoto Y; Masuda N; Yasojima H; Inao T; Osako T; Takahashi M; Tomioka N; Endo Y; Hosoda M; Doihara H; Miyoshi S; Yamashita H;
Breast Cancer Res; 2016 Jul; 18(1):73. PubMed ID: 27368476
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
